ArticlePediatric gastroenterology, hepatology & nutrition2025
Long-Term Response Durability of Infliximab for Pediatric Inflammatory Bowel Disease in Japan: A Single Center Experience.
Naoya Tsumura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.